Notice of Clarification to Eligibility Information in RFA-AI-20-023 “Limited Competition: International Epidemiology Databases to Evaluate AIDS (IeDEA) (U01 Clinical Trial Not Allowed)”
Notice Number:
NOT-AI-20-052

Key Dates

Release Date:

Related Announcements

RFA-AI-20-023 - Limited Competition: International Epidemiology Databases to Evaluate AIDS (IeDEA) (U01 Clinical Trial Not Allowed)

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to clarify the eligibility information in RFA-AI-20-023 “Limited Competition: International Epidemiology Databases to Evaluate AIDS (IeDEA) (U01 Clinical Trial Not Allowed).”

The following change has been made:

Part 2. Full Text of Announcement

Section III. Eligibility Information

1. Eligible Applicants

Eligible Organizations

Currently reads:

This limited competition is open to the following organizations/institutions only:

Only renewal applications from the current IeDEA Regional Data Centers may be submitted in response to this FOA:

Foundation for AIDS Research (New York, NY) – Asia Pacific region
Indiana University (Indianapolis, IN) – East Africa region
Johns Hopkins University (Baltimore, MD) – North America region
ADERA (France) – West Africa region
Vanderbilt University (Nashville, TN) – Central, South America and Caribbean region
University of Bern (Switzerland) – Southern Africa region
Albert Einstein College of Medicine (New York, NY) – Central Africa region

Revised to read:

This limited competition is open to the following organizations/institutions only:

Only renewal applications from the current IeDEA Regional Data Centers may be submitted in response to this FOA:

Foundation for AIDS Research (New York, NY) – Asia Pacific region
Indiana University (Indianapolis, IN) – East Africa region
Johns Hopkins University (Baltimore, MD) – North America region
ADERA (France) – West Africa region
Vanderbilt University Medical Center (Nashville, TN) – Central, South America and Caribbean region
University of Bern (Switzerland) – Southern Africa region
Albert Einstein College of Medicine (New York, NY) – Central Africa region

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Lori Zimand, MBA, MPH
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3212
Email: lzimand@niaid.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices